The DOI matches its Crossref record; 235 of the 238 references it cites were found in a registry or an index.
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Abstract
Accumulating evidence points to the causal role of triglyceride-rich lipoproteins and their cholesterol-enriched remnants in atherogenesis. Genetic studies in particular have not only revealed a relationship between plasma triglyceride levels and the risk of atherosclerotic cardiovascular disease, but have also identified key proteins responsible for the regulation of triglyceride transport. Kinetic studies in humans using stable isotope tracers have been especially useful in delineating the function of these proteins and revealing the hitherto unappreciated complexity of triglyceride-rich lipoprotein metabolism. Given that triglyceride is an essential energy source for mammals, triglyceride transport is regulated by numerous mechanisms that balance availability with the energy demands of the body. Ongoing investigations are focused on determining the consequences of dysregulation as a result of either dietary imprudence or genetic variation that increases the risk of atherosclerosis and pancreatitis. The identification of molecular control mechanisms involved in triglyceride metabolism has laid the groundwork for a 'precision-medicine' approach to therapy. Novel pharmacological agents under development have specific molecular targets within a regulatory framework, and their deployment heralds a new era in lipid-lowering-mediated prevention of disease. In this Review, we outline what is known about the dysregulation of triglyceride transport in human hypertriglyceridaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A decrease of 1 mmol/L (88.57 mg/dL) in triglycerides has been linked to roughly a 25% reduction in cardiovascular disease risk [24, 25]”
From Ketogenic diet-induced changes in adult lipid metabolism: a comprehensive systematic review and meta-regression of randomized controlled trials (2026) · cites this paper as [24]
In the citing paper
“In the postprandial state, CM are assembled in enterocytes through the packaging of dietary TG, cholesterol, and apolipoprotein B48 [10].”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [10]
In the citing paper
“In parallel, hepatocytes continuously secrete VLDL particles containing apolipoprotein B100, incorporating TG derived from de novo lipogenesis, circulating non-esterified fatty acids, hepatic lipid stores, and remnant uptake [10].”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [10]
In the citing paper
“TRLs, primarily chylomicrons (CM) and very low-density lipoproteins (VLDL), are secreted by the intestine and liver, respectively, and are the main vehicles for TG transport in the circulation.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [10]
In the citing paper
“Hypercholesterolemia, defined by elevated plasma low‐density lipoprotein (LDL) cholesterol, is a well‐established risk factor not only for cardiovascular disease (Borén et al. 2022; Steinberg 2013; Tabas et al. 2015; Boffa and Koschinsky 2019), but also for cognitive decline and dementia in later life (Kivipelto et al. 2001; Kivipelto and Solomon 2006; Livingston et al. 2024; Sparks et al. 2000, 2”
From LDL Cholesterol Modulates Astrocyte Metabolism, Lipid Handling, and Morphology: Evidence From In Vitro and In Vivo Models (2026) · cites this paper as Borén et al. 2022
Citations
Cites
Items 201–235 of 235
Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
Faghihnia, N., Mangravite, L. M., Chiu, S., Bergeron, N., & Krauss, R. M. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.118 · Cited by 36
Physical State of Lipids and Foreign Substances Producing Atherosclerosis
Moreton, J. R. (1948) · Science · doi:10.1126/science.107.2780.371 · Cited by 36
VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin
Lewis, G. F., Zinman, B., Uffelman, K. D., Szeto, L., Weller, B., & Steiner, G. A. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.4.e566 · Cited by 35
Cabodevilla, A. G., Tang, S., Lee, S., Mullick, A. E., Alemán, J. O., Hussain, M. M., Sessa, W. C., Abumrad, N. A., & Goldberg, I. J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145800 · Cited by 35
Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization
Xiao, C., Stahel, P., Nahmias, A., & Lewis, G. F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01604 · Cited by 34
Sakamoto, K., Kawamura, M., Kohro, T., Omura, M., Watanabe, T., Ashidate, K., Horiuchi, T., Hara, H., Sekine, N., Chin, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138332 · Cited by 32
Lipid effects of glucagon-like peptide 1 receptor analogs
Berberich, A. J., & Hegele, R. A. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000750 · Cited by 32
Taskinen, M., Björnson, E., Kahri, J., Söderlund, S., Matikainen, N., Porthan, K., Ainola, M., Hakkarainen, A., Lundbom, N. M. I., Fermanelli, V., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315446 · Cited by 31
Self-citationApoB SURFs a Ride from the ER to the Golgi
Ginsberg, H. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.007 · Cited by 30
Apolipoprotein B: from editosome to proteasome.
Chan, L., Chang, B. H., Liao, W. S. ‐., Oka, K., & Lau, P. P. (2000) · PubMed · Cited by 27
CERIELLO, A., Taboga, C., L, T., Quagliaro, L., Piconi, L., Bais, B., R, D. R., & Motz, E. (2002) · Institutional Research Information System (University of Udine) · Cited by 27
HDL in Morbidity and Mortality: A 40+ Year Perspective
Tall, A. R. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa148 · Cited by 26
Lipolytic enzymes and free fatty acids at the endothelial interface
Goldberg, I. J., Cabodevilla, A. G., Samovski, D., Cifarelli, V., Basu, D., & Abumrad, N. A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.018 · Cited by 25
Rabacchi, C., D’Addato, S., Palmisano, S., Lucchi, T. A., Bertolini, S., Calandra, S., & Tarugi, P. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.03.009 · Cited by 24
Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks
Stahel, P., Xiao, C., Nahmias, A., Tian, L., & Lewis, G. F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab008 · Cited by 24
Daytime triglyceride variability in men and women with different levels of triglyceridemia
Klop, B., Cohn, J. S., van Oostrom, A. J. H. H. M., van Wijk, J. P. H., Birnie, E., & Cabezas, M. C. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.08.010 · Cited by 23
Nahmias, A., Stahel, P., Tian, L., Xiao, C., & Lewis, G. F. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316311 · Cited by 23
Arsenault, B. J., Perrot, N., & Puri, R. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1110 · Cited by 21
Reimund, M., Wolska, A. T., Risti, R., Wilson, S. R., Sviridov, D. O., Remaley, A. T., & Lõokene, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.130 · Cited by 18
Carbohydrates: Separating fact from fiction
Blaak, E. E., Riccardi, G., & Cho, L. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.03.025 · Cited by 18
Transcriptomic Therapy for Dyslipidemias Utilizing Nucleic Acids Targeted at ANGPTL3
Watts, G. F., Raal, F. J., & Chan, D. C. (2021) · Future Cardiology · doi:10.2217/fca-2021-0096 · Cited by 18
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H., César, L. A. M., Tanaka, A., Schaefer, E. J., Maranhão, R. C., & Santos, R. D. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.008 · Cited by 17
Levy, E. H., Beaulieu, J., & Spahis, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.629222 · Cited by 16
Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle
Valladolid‐Acebes, I., Berggren, P., & Juntti‐Berggren, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020932 · Cited by 16
Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans
Borén, J., Adiels, M., Björnson, E., Matikainen, N., Söderlund, S., Rämö, J. T., Henricsson, M., Ripatti, P., Ripatti, S., Palotie, A. V., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13375 · Cited by 16
Self-citationA tale of 2 cousins: An atypical and a typical case of abetalipoproteinemia
Paquette, M., Dufour, R., Hegele, R. A., & Baass, A. W. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.01.003 · Cited by 14
A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome
Paquette, M., Hegele, R. A., Paré, G., & Baass, A. W. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.011 · Cited by 14
Toth, P. P., Bays, H. E., Brown, W. V., Catapano, A. L., Davidson, M. H., Farnier, M., Tomassini, J. E., Jensen, E. H., Polis, A. B., & Tershakovec, A. M. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.09.001 · Cited by 10
Basu, A., Jenkins, A. J., Stoner, J. A., Zhang, Y., Klein, R. L., Lopes-Virella, M. F., Garvey, W. T., Schade, D. S., Wood, J., Alaupovic, P., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p080143 · Cited by 8
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
Ginsberg, H. N., & Reyes‐Soffer, G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131333 · Cited by 7
Ruppert, P. M. M., & Kersten, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.h120.012744 · Cited by 7
Long-lost friend is back in the game
Kersten, S. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100072 · Cited by 5
Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline
Xu, J., & Ashjian, E. J. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211053489 · Cited by 4
Regulation of Intestinal Chylomicron Production by Glucagon-Like Peptides
Hsieh, J., & Adeli, K. (2012) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x11202020092 · Cited by 2
Gencer, B. F., Djoussé, L., Al-Ramady, O. T., Cook, N. R., Manson, J. E., & Albert, C. M. (2021) · doi:10.48350/159997 · Cited by 2
Research works printed but not linked: 1
- Chan, L. et al. From editosome to proteasome. Recent. Prog. Horm. Res. 55, 93–125 (2000). discussion 126.
Cited by
Sorted by citations
Björnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183
“1–5 In analogy with the pathogenic mechanisms linked to low-density lipoproteins (LDL), remnant lipoproteins can penetrate the sub-endothelial space in artery walls and bind to proteoglycans, thereby initiating cholesterol deposition and foam cell formation.”
Self-citationLi, Z., Zhang, B., Liu, Q., Tao, Z., Ding, L., Guo, B., Zhang, E., Zhang, H., Meng, Z., Guo, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104543 · Cited by 136
Zhao, Y., Zhuang, Z., Li, Y., Xiao, W., Song, Z., Huang, N., Wang, W., Dong, X., Jia, J., Clarke, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46686-x · Cited by 117
Xu, H., She, P., Zhao, Z., Ma, B., Li, G., & Wang, Y. (2023) · Advanced Materials · doi:10.1002/adma.202300439 · Cited by 103
Apolipoprotein B-containing lipoproteins in atherogenesis
Borén, J., Packard, C. J., & Binder, C. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01111-0 · Cited by 110
Self-citation
Metadata
- Authors
- Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J.
- Affiliations
- University of Gothenburg (SE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Borén, Jan
- Venue
- Nature Reviews Cardiology
- Published
- 2022-03-22
- Volume
- 19
- Issue
- 9
- Pages
- 577-592
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W4220891222
- Semantic Scholar
- 43b00c155f869658a4650440b8527740c6158985
- Cited by
- 315
- References
- 238
- Citations by year
- 2026: 74 · 2025: 99 · 2024: 78 · 2023: 48 · 2022: 14
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- triglyceride-rich lipoproteins, lipoprotein metabolism, hypertriglyceridemia, dyslipidemia, atherogenesis, atherosclerotic cardiovascular disease, triglyceride transport, lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, stable isotope tracers, genetic variation, pancreatitis, lipid-lowering therapy, precision medicine
- MeSH terms
- Animals, Humans, Kinetics, Lipoproteins, Mammals, Triglycerides, Hypertriglyceridemia, Dyslipidemias, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
